Stay updated on GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.

Latest updates to the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry v3.6.4 was added to the study record history, and the previous revision v3.6.3 was removed. This update reflects a new version stamp for the record.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision label in the history view updated from v3.6.2 to v3.6.3. This indicates a new site update for the record history interface without changing the underlying study data or how the page functions.SummaryDifference0.1%

- Check40 days agoChange DetectedA new revision entry v3.6.2 was added to the study record history, and the previous v3.6.0 entry was removed. This reflects an update to the page’s revision metadata rather than substantive study information.SummaryDifference0.1%

- Check54 days agoChange DetectedThe history now includes a note that the study is no longer looking for participants and adds the revision tag v3.6.0, while removing the previous revision v3.5.5.SummaryDifference0.3%

- Check61 days agoChange DetectedThe study history now shows Revision: v3.5.5 added and Revision: v3.5.4 removed, updating the page's version trail.SummaryDifference0.1%

- Check82 days agoChange DetectedThe history now includes Revision: v3.5.4, replacing Revision: v3.5.3; this indicates a small software update for ClinicalTrials.gov without altering study details.SummaryDifference0.1%

Stay in the know with updates to GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.